Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Cer 18:0;O2/26:1)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003645 AN005984 Targeting the c-MYC/ELOVL6 Pathway Alters Cell Membrane Mechanics and Enhances Chemotherapeutic Efficacy in Pancreatic Cancer Cultured cells Human Cancer Universidad Francisco de Vitoria - Hospital 12 de Octubre LC-MS
ST003630 AN005963 Individual glycemic responses to carbohydrates vary and reflect underlying metabolic physiology (Lipidomics) Blood Human Cardiovascular disease Stanford University LC-MS
ST003578 AN005876 NRF2 supports non-small cell lung cancer growth independently of CBP/p300-enhanced glutathione synthesis Cultured cells Human Cancer Genentech Inc. FIA-MS
ST003528 AN005796 Lipidomics profiling of livers from Alb-Cre +/- SART-/- (KO) versus age matched wild type WT mouse littermates to characterize progression to hepatic steatosis and hepatocellular carcinoma Liver Mouse Cancer University of Utah LC-MS
ST003527 AN005794 Combining antibiotics alters the longitudinal maturation of gut microbiota and its short chain fatty acid metabolites in extremely and very preterm infants Feces Human Gastrointestinal disease Seoul National University GC-MS/LC-MS
ST003403 AN005585 The double-edged role of FASII regulator FabT in Streptococcus pyogenes infection - Metabolomics Bacterial cells Streptococcus pyogenes Bacterial infection INSERM LC-MS
ST003090 AN005054 Analysis of lipid profiles of N2A-Pz1-KO cells expressing tdTOMATO-vector (mock), TMEM120A, or TMEM120B Cultured cells Mouse Rutgers University LC-MS
ST002937 AN004822 Deep Metabolic Phenotyping of Newborn Cord Blood Reveals Maternal-Fetal Interactions and Disease Risk Blood Human Stanford University LC-MS
ST002911 AN004780 LiLA: Lipid Lung-based ATLAS built Through a Comprehensive Workflow Designed for an Accurate Lipid Annotation Lung Mouse Tuberculosis Universidad CEU San Pablo LC-MS
ST002911 AN004781 LiLA: Lipid Lung-based ATLAS built Through a Comprehensive Workflow Designed for an Accurate Lipid Annotation Lung Mouse Tuberculosis Universidad CEU San Pablo LC-MS
ST002732 AN004429 Impaired metabolism predicts coronary artery calcification in women with systemic lupus erythematosus Blood Human Systemic lupus erythematosus INSERM LC-MS
ST002411 AN003930 Spatial, temporal, and inter-subject variation of the metabolome along the human upper intestinal tract (MS RP negative data) Intestine Human University of California, Davis LC-MS
ST002400 AN003908 Alcohol dehydrogenase 1B is crucial for adipocyte homeostasis Cultured cells Human INSERM LC-MS
ST002334 AN003810 Phospholipase D3 impact on the endolysosomal lipidome Cultured cells Human Alzheimers disease VIB-KU Leuven LC-MS
ST002283 AN003730 The “ForensOMICS” approach to forensic post-mortem interval estimation: combining metabolomics, lipidomics and proteomics for the analysis human skeletal remains Bone Human University of Central Lancashire LC-MS
ST002180 AN003571 Global, distinctive and personal changes in molecular and microbial profiles induced by specific fibers in humans (Targeted) Blood Human Stanford University LC-MS
ST002070 AN003375 Lipidomic Comparison of 2D and 3D Colon Cancer Cell Culture Models Cultured cells Human Cancer Ohio State University LC-MS
ST002023 AN003293 A targeted metabolomics study for assessing rodent thyroid toxicity Liver Rat Thyroid toxicity Helmholtz Centre for Environmental Research LC-MS
ST002023 AN003293 A targeted metabolomics study for assessing rodent thyroid toxicity Thyroid Rat Thyroid toxicity Helmholtz Centre for Environmental Research LC-MS
ST001942 AN003184 Lipidomics of esophageal adenocarcinoma Esophagus Human Cancer QIMR Berghofer Medical Research Institute LC-MS
ST001936 AN004932 Pseudoexfoliation aqueous humor lipidome suggests enrichment of specific pathways Eye tissue Human Pseudoexfoliation syndrome University of Miami LC-MS
ST001687 AN002754 Non-transformed cells respond to fat by inducing glucose metabolism Liver Mouse VIB-KU Leuven Center for Cancer Biology LC-MS
ST001490 AN002469 Plasma lipidomic profiles after a low and high glycemic load dietary pattern in a randomized controlled cross over feeding study Blood Human Fred Hutchinson Cancer Research Center FIA-MS
ST001345 AN002239 C56BL6 WT or IFNARKO BMDM stimulated with different TLRs (part-V) Macrophages Mouse University of California, Los Angeles MS(Dir. Inf.)
ST001344 AN002238 C56BL6 WT or MyD88KO BMDM stimulated with different TLRs (part-IV) Macrophages Mouse University of California, Los Angeles MS(Dir. Inf.)
ST001342 AN002236 Timecourse of C56BL6 BMDM stimulated with different TLRs (part-I) Macrophages Mouse University of California, Los Angeles MS(Dir. Inf.)
ST001341 AN002235 C56BL6 BMDM stimulated with different TLRs W/O acetylated LDL (part-II) Macrophages Mouse University of California, Los Angeles MS(Dir. Inf.)
ST001332 AN002221 LCMS lipid and acyl-carnitine analysis Worms C. elegans Environmental exposure University of Cambridge LC-MS
ST001289 AN002142 Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses Macrophages Mouse LIPID MAPS GC-MS/LC-MS
ST001288 AN002141 Subcellular organelle lipidomics in TLR-4-activated macrophages Macrophages Mouse LIPID MAPS LC-MS
ST000917 AN001501 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 3:Urine Urine Human Fatty liver disease LIPID MAPS GC-MS/LC-MS
ST000916 AN001495 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Plasma Blood Human Fatty liver disease LIPID MAPS GC-MS/LC-MS
ST000915 AN001489 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Liver Liver Human Fatty liver disease LIPID MAPS GC-MS/LC-MS
ST000005 AN000012 Timecourse on RAW 264.7 cells treated with Kdo2-Lipid A and compactin Macrophages Mouse LIPID MAPS GC-MS/LC-MS
ST000004 AN000006 Lipidomics studies on NIDDK / NIST human plasma samples Blood Human LIPID MAPS LC-MS
  logo